The pharmaceutical potential of AR‐65, a novel Alzheimer’s disease drug targeting the immunoproteasome Article

Park, Ji Eun, Bhattarai, Deepak, Park, Yujin et al. (2022). The pharmaceutical potential of AR‐65, a novel Alzheimer’s disease drug targeting the immunoproteasome . ALZHEIMERS & DEMENTIA, 18(S10), 10.1002/alz.064511

cited authors

  • Park, Ji Eun; Bhattarai, Deepak; Park, Yujin; Lee, Min Jae; Son, Sumin; Kim, Dong‐Eun; Kim, Kyung Bo

authors

publication date

  • December 1, 2022

published in

keywords

  • 2 Aetiology
  • 2.1 Biological and endogenous factors
  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3209 Neurosciences
  • 5 Development of treatments and therapeutic interventions
  • 5.1 Pharmaceuticals
  • Acquired Cognitive Impairment
  • Aging
  • Alzheimer's Disease
  • Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
  • Brain Disorders
  • Dementia
  • Neurodegenerative
  • Neurological
  • Neurosciences

Digital Object Identifier (DOI)

publisher

  • Wiley

volume

  • 18

issue

  • S10